Where it is registered
Each register with its number of medicines and a few of them.
Serbia
ALIMS · 10 medicines
- Litak®2mg/ml · rastvor za injekciju · Uni-Chem DOO.
- Mavenclad®10mg · tableta · Merck D.O.O. Beograd
- Mavenclad®10mg · tableta · Merck D.O.O. Beograd
- Mavenclad®10mg · tableta · Merck D.O.O. Beograd
Canada
Health Canada · 6 medicines
- Apo-Cladribine10 MG · Tablet · Apotex INC
- Auro-Cladribine10 MG · Tablet · Auro Pharma INC
- Cladribine Injection1 MG / ML · Solution · Fresenius Kabi Canada LTD
- Cladribine Injection1 MG / ML · Solution · Generic Medical Partners INC
Spain
AEMPS · 5 medicines
All medicines with Cladribine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
49 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cladribine | United States | 1MG/ML | injectable | Marketed | Hisun Pharm Hangzhou |
| Cladribine | United States | 10MG | tablet | Marketed | Apotex |
| Cladribine Injection | Canada | 1 MG / ML | Solution | Marketed | Fresenius Kabi Canada LTD |
| Cladribine Injection | Canada | 1 MG / ML | Solution | Marketed | Generic Medical Partners INC |
| Apo-Cladribine | Canada | 10 MG | Tablet | Marketed | Apotex INC |
| Auro-Cladribine | Canada | 10 MG | Tablet | Marketed | Auro Pharma INC |
| Mavenclad | United States | 10MG | tablet | Marketed | Emd Serono INC |
| Leustatin | United States | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Janssen Pharms |
| Mavenclad | European Union | Authorised | Merck Europe B.V. | ||
| Mavenclad 10 MG Comprimidos | Spain | 10 mg | comprimido | Marketed | Merck Europe B.V. |
| Mavenclad | Italy | Compressa | Authorised | Merck Europe B.V. | |
| Mavenclad 10 mg tabletten | Netherlands | Tablet | Authorised | Merck Europe B.V. | |
| Mavenclad | Canada | 10 MG | Tablet | Marketed | Emd Serono, A Division of Emd INC., Canada |
| Leustatin 1 MG/ML Solucion Para Perfusion | Spain | 10 mg | solución inyectable | Marketed | Atnahs Pharma Netherlands Bv. |
| Litak | European Union | Authorised | Lipomed GmbH | ||
| LITAK 2 mg/ml SOLUCION INYECTABLE | Spain | 2 mg | solución inyectable | Marketed | Lipomed Gmbh |
| LITAK 2 mg/ml SOLUCION INYECTABLE | Spain | 2 mg | solución inyectable | Marketed | Lipomed Gmbh |
| Leustatin, concentraat voor infusievloeistof 1 mg/ml | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Atnahs Pharma Netherlands B.V. | |
| Mavenclad | Brazil | Authorised | Merck S/A | ||
| Leustatin | Italy | Soluzione iniettabile | Authorised | Atnahs Pharma Netherlands BV | |
| Leustatin 2 mg/ml oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Atnahs Pharma Netherlands B.V. | |
| Leustatin 2 MG/ML Solucion Inyectable | Spain | 2 mg/ml | solución inyectable | Authorised | Atnahs Pharma Netherlands Bv. |
| Litak | Italy | Soluzione iniettabile | Authorised | Lipomed GMBH | |
| Litak, oplossing voor injectie 2 mg/ml | Netherlands | Oplossing voor injectie | Authorised | Lipomed GmbH | |
| Mavenclad® | Serbia | 10mg | tableta | Authorised | Merck D.O.O. Beograd |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Names in the registers
How the registers write it, in their own languages.
- Cladribina
- Cladribinum
- Kladribin
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 14
- Medicines
- 49
- Companies
- 22